No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
www.yidutech.comNo one on the platform currently holds 2158.HK.
No tracked institution reports a position in 2158.HK as of their last filing.
No one on the platform has traded 2158.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | -2.8% | — | — | — | ||
| Rev. Growth % | 10.6% | -1.8% | ||||
| Profit Margin % | 8.9% | -34.3% | ||||
| Free Cash Flow Margin % | -6.5% | -40.4% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $998M | +21.8% | $0.08 | $0.07–$0.09 | — | 1 |
| 2028 | $1.1B | +10.9% | $0.12 | $0.10–$0.14 | — | 2 |
| 2029 | $922M | -16.7% | $0.11 | $0.10–$0.11 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-06-29 | $-0.17 | $0.09 | +153.8% |
| 2025-11-27 | $-0.17 | $-0.01 | +93.5% |
| 2025-06-25 | $-0.17 | $-0.08 | +55.4% |
| 2024-11-21 | $-0.17 | $-0.04 | +73.7% |
| 2024-06-27 | $-0.12 | $-0.12 | +0.2% |
| 2023-11-29 | $-0.24 | $-0.08 | +68.2% |
| 2023-06-30 | $-0.26 | $-0.32 | -21.7% |
| 2022-11-25 | $-0.19 | $-0.40 | -111.8% |
| $13.76 |
| +1.93% |
| $4.4B |
| — |
| 1789.HKAK Medical Holdings Limited | $4.86 | -0.51% | $5.2B | — |
| 1951.HKJinxin Fertility Group Limited | $2.13 | +1.67% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry